E218-1483 Screening compound: 7-{2-[butyl(ethyl)amino]ethyl}-N~6~-cyclooctyl-6-methyl-8-oxo-5,6,7,8-tetrahydrofuro[2',3':4,5]pyrrolo[1,2-a]pyrazine-6-carboxamide

E218-1483 Screening compound: 7-{2-[butyl(ethyl)amino]ethyl}-N~6~-cyclooctyl-6-methyl-8-oxo-5,6,7,8-tetrahydrofuro[2',3':4,5]pyrrolo[1,2-a]pyrazine-6-carboxamide
E218-1483 Screening compound: 7-{2-[butyl(ethyl)amino]ethyl}-N~6~-cyclooctyl-6-methyl-8-oxo-5,6,7,8-tetrahydrofuro[2',3':4,5]pyrrolo[1,2-a]pyrazine-6-carboxamide alternative view

Chemical Structure Depiction of ChemDiv screening compound E218-1483
7-{2-[butyl(ethyl)amino]ethyl}-N~6~-cyclooctyl-6-methyl-8-oxo-5,6,7,8-tetrahydrofuro[2',3':4,5]pyrrolo[1,2-a]pyrazine-6-carboxamide

Available from 1 mg

Formats:

  • Glass Vials (4ml Glass Vials VWR #97047-678)
  • 96-tube racks (Matrix #4247 96-well 1.4ml sealed with capmats, empty cols 1 & 12, 100uL of 10mM)

Shiptime: 1 week worldwide delivery in most cases

Compound Identifiers

ChemDiv Compound ID

E218-1483

Molecular Formula

C27H42N4O3 (C27 H42 N4 O3)

Compound Name

7-{2-[butyl(ethyl)amino]ethyl}-N~6~-cyclooctyl-6-methyl-8-oxo-5,6,7,8-tetrahydrofuro[2',3':4,5]pyrrolo[1,2-a]pyrazine-6-carboxamide

IUPAC name

10-{2-[butyl(ethyl)amino]ethyl}-N-cyclooctyl-11-methyl-9-oxo-5-oxa-110-diazatricyclo[6.4.0.0^{26}]dodeca-2(6)37-triene-11-carboxamide

SMILES

CCCCN(CC)CCN(C(C)(Cn1c2cc3c1cco3)C(NC1CCCCCCC1)=O)C2=O

InChI

InChI=1S/C27H42N4O3/c1-4-6-15-29(5-2)16-17-31-25(32)23-19-24-22(14-18-34-24)30(23)20-27(31,3)26(33)28-21-12-10-8-7-9-11-13-21/h14,18-19,21H,4-13,15-17,20H2,1-3H3,(H,28,33)/t27-/m0/s1

InChI Key

GKBKIBXVZWPMNX-MHZLTWQESA-N

MDL Number (MFCD)

MFCD14848568

Chemical and Physical Properties

Saltdata

n/a

Molecular Weight

470.66

Hydrogen Bond Acceptors Count

6.00

Hydrogen Bond Donors Count

1.00

Rotatable Bond Count

10.00

Number of Nitrogen and Oxygen Atoms

7

Partition Coefficient, logP

5.296

Distribution Coefficient, logD

4.619

Water Solubility, LogSw

-5.15

Polar Surface Area

53.455

Acid Dissociation Constant (pKa)

13.87

Base Dissociation Constant (pKb)

7.97

Number of Chiral Centers

1.00

Percent sp3 carbon bonding

70.40

E218-1483 in Drug Discovery

Included in Screening Libraries

Antiviral Library (67538 compounds)

CNS Targets (44014 compounds)

Cyclic Ugi PPI Library (9586 compounds)

Protein Arginine Methyltransferases Library (27925 compounds)

Protein-Protein Interaction Library (218420 compounds)

Akt-Targeted Library (14764 compounds)

Included in 1.7M Stock Database

Therapeutical areas:
  • Antiviral
  • Infections
  • Immune system
  • Nervous system
  • Cancer
  • Musculoskeletal
  • Digestive system
  • Respiratory tract
  • Male
  • Female
  • Hemic and lymphatic
  • Metabolic
  • Digestive system
  • Respiratory tract
  • Male
  • Female
  • Hemic and lymphatic
  • Skin
Mechanism of action:
  • PPI modulators
  • Epigenetic
  • PPI modulators
Structure:
  • Cyclic compounds
Targets:
  • Others
  • Kinases

References: we are preparing a list of scientific research reports with E218-1483 chemical compound. It will be published here after verification.

Frequently Asked Questions

How to purchase chemical compound E218-1483?
Check Price and Availability of E218-1483, then you can add required amount to the Shopping Cart. In the Shopping Cart you can again refine your selection. Once you are sure that it’s exactly what you want you can move forward with the Checkout (to pay online by credit card, or via PayPal), or Request a Quote.
What is the minimum amount of E218-1483 you sell to drug discovery company or institution?
Available from 1 mg in Glass Vials or 96-tube racks.
Delivery options for E218-1483
ChemDiv sends parcels with Express services (UPS, WC).
  • 1–2 days for small orders
  • 2–4 weeks for large selections
Delivery formats for E218-1483
  • 0.5–50 mg of dry powder sample in single glass vials, custom vials
  • DMSO solutions frozen 10μl–250μl@10mM (96 and 384 format)

Custom synthesis of E218-1483 available by request